Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease - Wilbraham, Darren; Biglan, Kevin M.; Svensson, Kjell A.; Tsai, Max; Pugh, Melissa; Ardayfio, Paul; Kielbasa, William (Clinical pharmacology in drug development, 2022)